In life sciences, research, advances in instrumentation, new types of measurements that are now possible and improved computational tools are generating not only significantly more data than ever before but also more diverse modalities and higher resolution data. Marilyn Matz and Zachary Pitluk at Paradigm4 discuss how pharma and biopharma organisations, can leverage the new ‘mountain’ of available data to open the potential for them to expedite the discovery and delivery of new, more effective, safer therapies for patients.
Current Edition
Current Edition
Subsection - CDMO
Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.
Continue readingSubsection - Injectables
Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.
Continue readingSubsection - Neurodegenerative Diseases
Exploring emerging approaches to neurodegenerative disease research and treatment.
Continue readingSubsection - Nasal & Pulmonary
Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.
Continue reading
